BDBM50010179 1N-[1-formyl-(1S)-ethylcarbamoylmethylcarbamoylmethyl]-2-[2-(1H-5-imidazolyl)-1-[2-(1H-5-imidazolyl)-1-methylcarboxamido-(1S)-ethylcarboxamido]-(1S)-ethylcarboxamido]-4-methyl-(2S)-pentanamide [4-Carbamoyl-16-(2,6-diamino-hexanoylamino)-13-(3-guanidino-propyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid::CHEMBL2370404
SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1c[nH]cn1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSSC(C)(C)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O)C(N)=O
InChI Key InChIKey=SRYSGNXPFWUXDV-ZQAHWTIOSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50010179
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair